{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:02:14Z","timestamp":1793275334581,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T00:00:00Z","timestamp":1302566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T00:00:00Z","timestamp":1302566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1038\/nrneurol.2011.43","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T08:53:10Z","timestamp":1302598390000},"page":"263-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":229,"title":["Corticobasal degeneration: a pathologically distinct 4R tauopathy"],"prefix":"10.1038","volume":"7","author":[{"given":"Naomi","family":"Kouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Whitwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Josephs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Rademakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,12]]},"reference":[{"key":"BFnrneurol201143_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1212\/WNL.48.1.119","volume":"48","author":"I Litvan","year":"1997","unstructured":"Litvan, I. et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 48, 119\u2013125 (1997).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR2","first-page":"53","volume":"82","author":"DM Togasaki","year":"2000","unstructured":"Togasaki, D. M. & Tanner, C. M. Epidemiologic aspects. Adv. Neurol. 82, 53\u201359 (2000).","journal-title":"Adv. Neurol."},{"key":"BFnrneurol201143_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.22966","volume":"25","author":"Y Winter","year":"2010","unstructured":"Winter, Y. et al. Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study. Mov. Disord. 25, 349\u2013356 (2010).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201143_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/archneur.1968.00470310034003","volume":"18","author":"JJ Rebeiz","year":"1968","unstructured":"Rebeiz, J. J., Kolodny, E. H. & Richardson, E. P. Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch. Neurol. 18, 20\u201333 (1968).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201143_CR5","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/brain\/112.5.1171","volume":"112","author":"WR Gibb","year":"1989","unstructured":"Gibb, W. R., Luthert, P. J. & Marsden, C. D. Corticobasal degeneration. Brain 112, 1171\u20131192 (1989).","journal-title":"Brain"},{"key":"BFnrneurol201143_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1750-3639.1998.tb00159.x","volume":"8","author":"C Bergeron","year":"1998","unstructured":"Bergeron, C., Davis, A. & Lang, A. E. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol. 8, 355\u2013365 (1998).","journal-title":"Brain Pathol."},{"key":"BFnrneurol201143_CR7","first-page":"282","volume-title":"Movement Disorders III: Blue Books of Practical Neurology","author":"RL Watts","year":"1994","unstructured":"Watts, R. L., Mirra, S. S. & Richarson, E. P. Jr in Movement Disorders III: Blue Books of Practical Neurology Vol. 13 (eds Marsden, C. D. & Fahn, S.) 282\u2013299 (Butterworth\u2013Heinemann, Oxford, 1994)."},{"key":"BFnrneurol201143_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1212\/WNL.38.7.1026","volume":"38","author":"DE Riley","year":"1988","unstructured":"Riley, D. E. & Lang, A. E. Corticobasal ganglionic degeneration (CBGD): further observations in six additional cases. Neurology 38, 360 (1988).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1212\/WNL.53.4.795","volume":"53","author":"BF Boeve","year":"1999","unstructured":"Boeve, B. F. et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 53, 795\u2013800 (1999).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR10","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1212\/WNL.40.8.1203","volume":"40","author":"DE Riley","year":"1990","unstructured":"Riley, D. E. et al. Cortical\u2013basal ganglionic degeneration. Neurology 40, 1203\u20131212 (1990).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0072-9752(07)01247-X","volume":"89","author":"TH Bak","year":"2008","unstructured":"Bak, T. H. & Hodges, J. R. Corticobasal degeneration: clinical aspects. Handb. Clin. Neurol. 89, 509\u2013521 (2008).","journal-title":"Handb. Clin. Neurol."},{"key":"BFnrneurol201143_CR12","first-page":"877","volume-title":"Neurodegenerative Diseases","author":"AE Lang","year":"1994","unstructured":"Lang, A. E., Riley, D. E. & Bergeron, C. in Neurodegenerative Diseases Ch. 49 (ed. Calne, D. B.) 877\u2013894 (W. B. Saunders, Philadelphia, 1994)."},{"key":"BFnrneurol201143_CR13","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","volume":"261","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal, I. et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261, 6084\u20136089 (1986).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol201143_CR14","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","volume":"128","author":"DR Williams","year":"2005","unstructured":"Williams, D. R. et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128, 1247\u20131258 (2005).","journal-title":"Brain"},{"key":"BFnrneurol201143_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.410400611","volume":"40","author":"C Bergeron","year":"1996","unstructured":"Bergeron, C., Pollanen, M. S., Weyer, L., Black, S. E. & Lang, A. E. Unusual clinical presentations of cortical\u2013basal ganglionic degeneration. Ann. Neurol. 40, 893\u2013900 (1996).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201143_CR16","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/01.wnl.0000259519.78480.c3","volume":"68","author":"R Murray","year":"2007","unstructured":"Murray, R. et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 68, 1274\u20131283 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR17","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awq123","volume":"133","author":"H Ling","year":"2010","unstructured":"Ling, H. et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133, 2045\u20132057 (2010).","journal-title":"Brain"},{"key":"BFnrneurol201143_CR18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/WNL.48.4.959","volume":"48","author":"JA Schneider","year":"1997","unstructured":"Schneider, J. A., Watts, R. L., Gearing, M., Brewer, R. P. & Mirra, S. S. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 48, 959\u2013969 (1997).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR19","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1212\/WNL.53.9.1969","volume":"53","author":"DA Grimes","year":"1999","unstructured":"Grimes, D. A., Lang, A. E. & Bergeron, C. B. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 53, 1969\u20131974 (1999).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR20","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1212\/WNL.55.9.1368","volume":"55","author":"A Kertesz","year":"2000","unstructured":"Kertesz, A., Martinez-Lage, P., Davidson, W. & Munoz, D. G. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55, 1368\u20131375 (2000).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/13554790490894011","volume":"10","author":"ML Gorno-Tempini","year":"2004","unstructured":"Gorno-Tempini, M. L., Murray, R. C., Rankin, K. P., Weiner, M. W. & Miller, B. L. Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report. Neurocase 10, 426\u2013436 (2004).","journal-title":"Neurocase"},{"key":"BFnrneurol201143_CR22","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/brain\/awl078","volume":"129","author":"KA Josephs","year":"2006","unstructured":"Josephs, K. A. et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129, 1385\u20131398 (2006).","journal-title":"Brain"},{"key":"BFnrneurol201143_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1155\/2007\/218189","volume":"18","author":"A Raggi","year":"2007","unstructured":"Raggi, A. et al. The clinical overlap between the corticobasal degeneration syndrome and other diseases of the frontotemporal spectrum: three case reports. Behav. Neurol. 18, 159\u2013164 (2007).","journal-title":"Behav. Neurol."},{"key":"BFnrneurol201143_CR24","first-page":"51","volume":"53","author":"WR Gibb","year":"1990","unstructured":"Gibb, W. R., Luthert, P. J. & Marsden, C. D. Clinical and pathological features of corticobasal degeneration. Adv. Neurol. 53, 51\u201354 (1990).","journal-title":"Adv. Neurol."},{"key":"BFnrneurol201143_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/jnnp.64.2.184","volume":"64","author":"GK Wenning","year":"1998","unstructured":"Wenning, G. K. et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J. Neurol. Neurosurg. Psychiatry 64, 184\u2013189 (1998).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201143_CR26","first-page":"183","volume":"82","author":"I Litvan","year":"2000","unstructured":"Litvan, I., Grimes, D. A. & Lang, A. E. Phenotypes and prognosis: clinicopathologic studies of corticobasal degeneration. Adv. Neurol. 82, 183\u2013196 (2000).","journal-title":"Adv. Neurol."},{"key":"BFnrneurol201143_CR27","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/brain\/awh598","volume":"128","author":"A Kertesz","year":"2005","unstructured":"Kertesz, A., McMonagle, P., Blair, M., Davidson, W. & Munoz, D. G. The evolution and pathology of frontotemporal dementia. Brain 128, 1996\u20132005 (2005).","journal-title":"Brain"},{"key":"BFnrneurol201143_CR28","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1212\/WNL.44.8.1436","volume":"44","author":"AE Lang","year":"1994","unstructured":"Lang, A. E., Bergeron, C., Pollanen, M. S. & Ashby, P. Parietal Pick's disease mimicking cortical\u2013basal ganglionic degeneration. Neurology 44, 1436\u20131440 (1994).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR29","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/1531-8257(199907)14:4<674::AID-MDS1019>3.0.CO;2-X","volume":"14","author":"DA Grimes","year":"1999","unstructured":"Grimes, D. A., Bergeron, C. B. & Lang, A. E. Motor neuron disease-inclusion dementia presenting as cortical\u2013basal ganglionic degeneration. Mov. Disord. 14, 674\u2013680 (1999).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201143_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s004010051087","volume":"98","author":"DS Horoupian","year":"1999","unstructured":"Horoupian, D. S. & Wasserstein, P. H. Alzheimer's disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol. 98, 317\u2013322 (1999).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol201143_CR31","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/mds.22574","volume":"24","author":"WT Hu","year":"2009","unstructured":"Hu, W. T. et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov. Disord. 24, 1375\u20131379 (2009).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201143_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nbd.2008.11.008","volume":"33","author":"L Benussi","year":"2009","unstructured":"Benussi, L. et al. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide. Neurobiol. Dis. 33, 379\u2013385 (2009).","journal-title":"Neurobiol. Dis."},{"key":"BFnrneurol201143_CR33","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1212\/WNL.0b013e3181feb2e8","volume":"75","author":"JL Whitwell","year":"2010","unstructured":"Whitwell, J. L. et al. Imaging correlates of pathology in corticobasal syndrome. Neurology 75, 1879\u20131887 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR34","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/01.wnl.0000286938.39473.0e","volume":"70","author":"DR Williams","year":"2008","unstructured":"Williams, D. R., Lees, A. J., Wherrett, J. R. & Steele, J. C. J. Clifford Richardson and 50 years of progressive supranuclear palsy. Neurology 70, 566\u2013573 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","volume":"10","author":"JC Steele","year":"1964","unstructured":"Steele, J. C., Richardson, J. C. & Olszewski, J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol. 10, 333\u2013359 (1964).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201143_CR36","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/mds.20478","volume":"20","author":"Y Tsuboi","year":"2005","unstructured":"Tsuboi, Y. et al. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov. Disord. 20, 982\u2013988 (2005).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201143_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00401-002-0531-y","volume":"104","author":"T Oide","year":"2002","unstructured":"Oide, T. et al. Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia. Acta Neuropathol. 104, 209\u2013214 (2002).","journal-title":"Acta Neuropathol."},{"issue":"Suppl. 2","key":"BFnrneurol201143_CR38","first-page":"II1","volume":"246","author":"I Litvan","year":"1999","unstructured":"Litvan, I. et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J. Neurol. 246 (Suppl. 2), II1\u2013II5 (1999).","journal-title":"J. Neurol."},{"issue":"Suppl. 2","key":"BFnrneurol201143_CR39","doi-asserted-by":"publisher","first-page":"II6","DOI":"10.1007\/BF03161076","volume":"246","author":"DW Dickson","year":"1999","unstructured":"Dickson, D. W. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J. Neurol. 246 (Suppl. 2), II6\u2013II15 (1999).","journal-title":"J. Neurol."},{"key":"BFnrneurol201143_CR40","first-page":"192","volume":"19","author":"M Shiozawa","year":"2000","unstructured":"Shiozawa, M. et al. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy. Clin. Neuropathol. 19, 192\u2013199 (2000).","journal-title":"Clin. Neuropathol."},{"key":"BFnrneurol201143_CR41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.parkreldis.2009.11.013","volume":"16","author":"A Hassan","year":"2010","unstructured":"Hassan, A. et al. Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat. Disord. 16, 208\u2013214 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol201143_CR42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/ana.410350408","volume":"35","author":"M Vidailhet","year":"1994","unstructured":"Vidailhet, M. et al. Eye movements in parkinsonian syndromes. Ann. Neurol. 35, 420\u2013426 (1994).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201143_CR43","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1212\/WNL.54.5.1029","volume":"54","author":"S Rivaud-P\u00e9choux","year":"2000","unstructured":"Rivaud-P\u00e9choux, S. et al. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology 54, 1029\u20131032 (2000).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR44","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/brain\/awh560","volume":"128","author":"C Zadikoff","year":"2005","unstructured":"Zadikoff, C. & Lang, A. E. Apraxia in movement disorders. Brain 128, 1480\u20131497 (2005).","journal-title":"Brain"},{"issue":"Suppl. 3","key":"BFnrneurol201143_CR45","doi-asserted-by":"publisher","first-page":"S341","DOI":"10.1016\/S1353-8020(08)70028-2","volume":"13","author":"DJ Houghton","year":"2007","unstructured":"Houghton, D. J. & Litvan, I. Unraveling progressive supranuclear palsy: from the bedside back to the bench. Parkinsonism Relat. Disord. 13 (Suppl. 3), S341\u2013S346 (2007).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol201143_CR46","first-page":"147","volume":"82","author":"JL Cummings","year":"2000","unstructured":"Cummings, J. L. & Litvan, I. Neuropsychiatric aspects of corticobasal degeneration. Adv. Neurol. 82, 147\u2013152 (2000).","journal-title":"Adv. Neurol."},{"key":"BFnrneurol201143_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2006.09.019","volume":"29","author":"KA Josephs","year":"2008","unstructured":"Josephs, K. A. et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol. Aging 29, 280\u2013289 (2008).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201143_CR48","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary, D. et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51, 1546\u20131554 (1998).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR49","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ana.20203","volume":"56","author":"JR Hodges","year":"2004","unstructured":"Hodges, J. R. et al. Clinicopathological correlates in frontotemporal dementia. Ann. Neurol. 56, 399\u2013406 (2004).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201143_CR50","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.20873","volume":"59","author":"MS Forman","year":"2006","unstructured":"Forman, M. S. et al. Frontotemporal dementia: clinicopathological correlations. Ann. Neurol. 59, 952\u2013962 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201143_CR51","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000209507","volume":"6","author":"JL Whitwell","year":"2009","unstructured":"Whitwell, J. L. et al. MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration. Neurodegener. Dis. 6, 106\u2013117 (2009).","journal-title":"Neurodegener. Dis."},{"key":"BFnrneurol201143_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/01.wnl.0000191307.69661.c3","volume":"66","author":"KA Josephs","year":"2006","unstructured":"Josephs, K. A. et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66, 41\u201348 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR53","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1212\/01.wnl.0000303816.25065.bc","volume":"70","author":"M Grossman","year":"2008","unstructured":"Grossman, M. et al. Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology 70, 2036\u20132045 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR54","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ana.91","volume":"49","author":"MM Mesulam","year":"2001","unstructured":"Mesulam, M. M. Primary progressive aphasia. Ann. Neurol. 49, 425\u2013432 (2001).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201143_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/ana.20700","volume":"59","author":"JA Knibb","year":"2006","unstructured":"Knibb, J. A., Xuereb, J. H., Patterson, K. & Hodges, J. R. Clinical and pathological characterization of progressive aphasia. Ann. Neurol. 59, 156\u2013165 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201143_CR56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrneurol.2009.216","volume":"6","author":"M Grossman","year":"2010","unstructured":"Grossman, M. Primary progressive aphasia: clinicopathological correlations. Nat. Rev. Neurol. 6, 88\u201397 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrneurol201143_CR57","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2990.2003.00545.x","volume":"30","author":"KA Josephs","year":"2004","unstructured":"Josephs, K. A. et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol. Appl. Neurobiol. 30, 369\u2013373 (2004).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrneurol201143_CR58","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archneur.1988.00520310107024","volume":"45","author":"DF Benson","year":"1988","unstructured":"Benson, D. F., Davis, R. J. & Snyder, B. D. Posterior cortical atrophy. Arch. Neurol. 45, 789\u2013793 (1988).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201143_CR59","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1212\/01.WNL.0000140290.80962.BF","volume":"63","author":"JA Renner","year":"2004","unstructured":"Renner, J. A. et al. Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology 63, 1175\u20131180 (2004).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR60","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1212\/01.WNL.0000140289.18472.15","volume":"63","author":"DF Tang-Wai","year":"2004","unstructured":"Tang-Wai, D. F. et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology 63, 1168\u20131174 (2004).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR61","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-010-0712-z","volume":"121","author":"KA Jellinger","year":"2011","unstructured":"Jellinger, K. A. et al. Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration? Acta Neuropathol. 121, 267\u2013277 (2011).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol201143_CR62","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","volume":"61","author":"DW Dickson","year":"2002","unstructured":"Dickson, D. W. et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J. Neuropathol. Exp. Neurol. 61, 935\u2013946 (2002).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol201143_CR63","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1365-2990.2004.00593.x","volume":"30","author":"Y Fujino","year":"2004","unstructured":"Fujino, Y., Delucia, M. W., Davies, P. & Dickson, D. W. Ballooned neurones in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity. Neuropathol. Appl. Neurobiol. 30, 676\u2013682 (2004).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrneurol201143_CR64","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/01.jnen.0000218446.38158.61","volume":"65","author":"KA Josephs","year":"2006","unstructured":"Josephs, K. A. et al. Atypical progressive supranuclear palsy with corticospinal tract degeneration. J. Neuropathol. Exp. Neurol. 65, 396\u2013405 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol201143_CR65","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1017\/CBO9780511526886.012","volume-title":"The Neuropathology of Dementia","author":"DW Dickson","year":"2004","unstructured":"Dickson, D. W. in The Neuropathology of Dementia Ch. 11 (eds Esiri, M. M. et al.) 227\u2013256 (Cambridge University Press, Cambridge, 2004)."},{"key":"BFnrneurol201143_CR66","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s004010050911","volume":"96","author":"T Komori","year":"1998","unstructured":"Komori, T. et al. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol. 96, 401\u2013408 (1998).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol201143_CR67","first-page":"1388","volume":"146","author":"MB Feany","year":"1995","unstructured":"Feany, M. B. & Dickson, D. W. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am. J. Pathol. 146, 1388\u20131396 (1995).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol201143_CR68","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0304-3940(92)90145-W","volume":"135","author":"T Yamada","year":"1992","unstructured":"Yamada, T., McGeer, P. L. & McGeer, E. G. Appearance of paired nucleated, tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci. Lett. 135, 99\u2013102 (1992).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol201143_CR69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ana.10793","volume":"55","author":"T Arai","year":"2004","unstructured":"Arai, T. et al. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann. Neurol. 55, 72\u201379 (2004).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201143_CR70","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/00001756-200104170-00014","volume":"12","author":"T Arai","year":"2001","unstructured":"Arai, T. et al. Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy. Neuroreport 12, 935\u2013938 (2001).","journal-title":"Neuroreport"},{"key":"BFnrneurol201143_CR71","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/jnen\/60.6.647","volume":"60","author":"K Ishizawa","year":"2001","unstructured":"Ishizawa, K. & Dickson, D. W. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J. Neuropathol. Exp. Neurol. 60, 647\u2013657 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol201143_CR72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/mds.20668","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard, A. et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy. Mov. Disord. 21, 89\u201393 (2006).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201143_CR73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","volume":"68","author":"K Bhaskar","year":"2010","unstructured":"Bhaskar, K. et al. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68, 19\u201331 (2010).","journal-title":"Neuron"},{"key":"BFnrneurol201143_CR74","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner, L. M. et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimers's disease mouse models. Cell 142, 387\u2013397 (2010).","journal-title":"Cell"},{"key":"BFnrneurol201143_CR75","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover, B. R. et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067\u20131081 (2010).","journal-title":"Neuron"},{"key":"BFnrneurol201143_CR76","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.expneurol.2009.08.031","volume":"223","author":"KR Brunden","year":"2010","unstructured":"Brunden, K. R. et al. Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors. Exp. Neurol. 223, 304\u2013310 (2010).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol201143_CR77","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","volume":"93","author":"CM Wischik","year":"1996","unstructured":"Wischik, C. M., Edwards, P. C., Lai, R. Y., Roth, M. & Harrington, C. R. Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc. Natl Acad. Sci. USA 93, 11213\u201311218 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201143_CR78","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2165\/11536110-000000000-00000","volume":"27","author":"CX Gong","year":"2010","unstructured":"Gong, C. X., Grundke-Iqbal, I. & Iqbal, K. Targeting tau protein in Alzheimer's disease. Drugs Aging 27, 351\u2013365 (2010).","journal-title":"Drugs Aging"},{"key":"BFnrneurol201143_CR79","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0014-5793(92)81496-9","volume":"314","author":"EM Mandelkow","year":"1992","unstructured":"Mandelkow, E. M. et al. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 314, 315\u2013321 (1992).","journal-title":"FEBS Lett."},{"key":"BFnrneurol201143_CR80","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3233\/JAD-2003-5405","volume":"5","author":"M P\u00e9rez","year":"2003","unstructured":"P\u00e9rez, M., Hernandez, F., Lim, F., Diaz-Nido, J. & Avila, J. Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model. J. Alzheimers Dis. 5, 301\u2013308 (2003).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol201143_CR81","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.1073\/pnas.0500466102","volume":"102","author":"W Noble","year":"2005","unstructured":"Noble, W. et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl Acad. Sci. USA 102, 6990\u20136995 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201143_CR82","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00401-005-1087-4","volume":"110","author":"H Nakashima","year":"2005","unstructured":"Nakashima, H. et al. Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies. Acta Neuropathol. 110, 547\u2013556 (2005).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol201143_CR83","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1471-4159.2006.04139.x","volume":"99","author":"T Engel","year":"2006","unstructured":"Engel, T., Go\u00f1i-Oliver, P., Lucas, J. J., Avila, J. & Hern\u00e1ndez, F. Chronic lithium administration to FTDP-17 tau and GSK-3\u03b2 overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. J. Neurochem. 99, 1445\u20131455 (2006).","journal-title":"J. Neurochem."},{"key":"BFnrneurol201143_CR84","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.2353\/ajpath.2007.061178","volume":"170","author":"A Caccamo","year":"2007","unstructured":"Caccamo, A., Oddo, S., Tran, L. X. & LaFerla, F. M. Lithium reduces tau phosphorylation but not A\u03b2 or working memory deficits in a transgenic model with both plaques and tangles. Am. J. Pathol. 170, 1669\u20131675 (2007).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol201143_CR85","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bbadis.2004.06.014","volume":"1739","author":"VM Lee","year":"2005","unstructured":"Lee, V. M., Kenyon, T. K. & Trojanowski, J. Q. Transgenic animal models of tauopathies. Biochim. Biophys. Acta 1739, 251\u2013259 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneurol201143_CR86","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1073\/pnas.0406361102","volume":"102","author":"B Zhang","year":"2005","unstructured":"Zhang, B. et al. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc. Natl Acad. Sci. USA 102, 227\u2013231 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201143_CR87","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.3233\/JAD-2004-6S605","volume":"6","author":"I Gozes","year":"2004","unstructured":"Gozes, I. & Divinski, I. The femtomolar-acting NAP interacts with microtubules: novel aspects of astrocyte protection. J. Alzheimers Dis. 6, S37\u2013S41 (2004).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol201143_CR88","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1385\/JMN\/31:02:165","volume":"31","author":"Y Matsuoka","year":"2007","unstructured":"Matsuoka, Y. et al. Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage. J. Mol. Neurosci. 31, 165\u2013170 (2007).","journal-title":"J. Mol. Neurosci."},{"key":"BFnrneurol201143_CR89","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1124\/jpet.107.130526","volume":"325","author":"Y Matsuoka","year":"2008","unstructured":"Matsuoka, Y. et al. A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease. J. Pharmacol. Exp. Ther. 325, 146\u2013153 (2008).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrneurol201143_CR90","doi-asserted-by":"publisher","first-page":"13861","DOI":"10.1523\/JNEUROSCI.3059-10.2010","volume":"30","author":"KR Brunden","year":"2010","unstructured":"Brunden, K. R. et al. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J. Neurosci. 30, 13861\u201313866 (2010).","journal-title":"J. Neurosci."},{"key":"BFnrneurol201143_CR91","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1073\/pnas.0701055104","volume":"104","author":"W Luo","year":"2007","unstructured":"Luo, W. et al. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies. Proc. Natl Acad. Sci. USA 104, 9511\u20139516 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201143_CR92","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1172\/JCI29715","volume":"117","author":"CA Dickey","year":"2007","unstructured":"Dickey, C. A. et al. The high-affinity HSP90\u2013CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J. Clin. Invest. 117, 648\u2013658 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol201143_CR93","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1074\/jbc.M410984200","volume":"280","author":"M Pickhardt","year":"2005","unstructured":"Pickhardt, M. et al. Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells. J. Biol. Chem. 280, 3628\u20133635 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol201143_CR94","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0304-3940(98)00923-9","volume":"259","author":"K Urakami","year":"1999","unstructured":"Urakami, K. et al. A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy. Neurosci. Lett. 259, 127\u2013129 (1999).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol201143_CR95","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-510X(00)00480-9","volume":"183","author":"K Urakami","year":"2001","unstructured":"Urakami, K. et al. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy. J. Neurol. Sci. 183, 95\u201398 (2001).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol201143_CR96","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neurobiolaging.2007.05.009","volume":"30","author":"B Borroni","year":"2009","unstructured":"Borroni, B. et al. Pattern of tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol. Aging 30, 34\u201340 (2009).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201143_CR97","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jns.2005.05.015","volume":"237","author":"M Noguchi","year":"2005","unstructured":"Noguchi, M. et al. Decreased \u03b2-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration. J. Neurol. Sci. 237, 61\u201365 (2005).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol201143_CR98","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s004150050173","volume":"245","author":"K Mitani","year":"1998","unstructured":"Mitani, K. et al. Increased CSF tau protein in corticobasal degeneration. J. Neurol. 245, 44\u201346 (1998).","journal-title":"J. Neurol."},{"key":"BFnrneurol201143_CR99","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1006\/bbrc.1997.6908","volume":"236","author":"H Arai","year":"1997","unstructured":"Arai, H. et al. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem. Biophys. Res. Commun. 236, 262\u2013264 (1997).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneurol201143_CR100","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1021\/pr7008669","volume":"7","author":"E Portelius","year":"2008","unstructured":"Portelius, E. et al. Characterization of tau in cerebrospinal fluid using mass spectrometry. J. Proteome Res. 7, 2114\u20132120 (2008).","journal-title":"J. Proteome Res."},{"key":"BFnrneurol201143_CR101","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00401-007-0209-6","volume":"113","author":"AL Guillozet-Bongaarts","year":"2007","unstructured":"Guillozet-Bongaarts, A. L. et al. Phosphorylation and cleavage of tau in non-AD tauopathies. Acta Neuropathol. 113, 513\u2013520 (2007).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol201143_CR102","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mds.870130116","volume":"13","author":"B Holmberg","year":"1998","unstructured":"Holmberg, B., Rosengren, L., Karlsson, J. E. & Johnels, B. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease. Mov. Disord. 13, 70\u201377 (1998).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201143_CR103","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1002\/mds.21124","volume":"21","author":"J Brettschneider","year":"2006","unstructured":"Brettschneider, J. et al. Neurofilament heavy-chain NfHSMI35 in cerebrospinal fluid supports the differential diagnosis of parkinsonian syndromes. Mov. Disord. 21, 2224\u20132227 (2006).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201143_CR104","volume-title":"Proc. CurePSP 2010 International Research Symposium","author":"U M\u00fcller","year":"2010","unstructured":"M\u00fcller, U. GWAS in PSP: results at disease-associated loci other than MAPT. Proc. CurePSP 2010 International Research Symposium (San Diego, CA, November 18, 2010)."},{"key":"BFnrneurol201143_CR105","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1046\/j.1471-4159.1999.0721243.x","volume":"72","author":"N Sergeant","year":"1999","unstructured":"Sergeant, N., Wattez, A. & Delacourte, A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively \u201cexon 10\u201d isoforms. J. Neurochem. 72, 1243\u20131249 (1999).","journal-title":"J. Neurochem."},{"key":"BFnrneurol201143_CR106","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.410430209","volume":"43","author":"A Delacourte","year":"1998","unstructured":"Delacourte, A., Sergeant, N., Wattez, A., Gauvreau, D. & Robitaille, Y. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann. Neurol. 43, 193\u2013204 (1998).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201143_CR107","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1212\/WNL.56.suppl_4.S21","volume":"56","author":"M Hutton","year":"2001","unstructured":"Hutton, M. Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. Neurology 56, S21\u2013S25 (2001).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR108","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","volume":"101","author":"LI Binder","year":"1985","unstructured":"Binder, L. I., Frankfurter, A. & Rebhun, L. I. The distribution of tau in the mammalian central nervous system. J. Cell. Biol. 101, 1371\u20131378 (1985).","journal-title":"J. Cell. Biol."},{"key":"BFnrneurol201143_CR109","doi-asserted-by":"publisher","first-page":"10369","DOI":"10.1073\/pnas.92.22.10369","volume":"92","author":"P LoPresti","year":"1995","unstructured":"LoPresti, P., Szuchet, S., Papasozomenos, S. C., Zinkowski, R. P. & Binder, L. I. Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc. Natl Acad. Sci. USA 92, 10369\u201310373 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201143_CR110","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1073\/pnas.73.11.4070","volume":"73","author":"GB Witman","year":"1976","unstructured":"Witman, G. B., Cleveland, D. W., Weingarten, M. D. & Kirschner, M. W. Tubulin requires tau for growth onto microtubule initiating sites. Proc. Natl Acad. Sci. USA 73, 4070\u20134074 (1976).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201143_CR111","doi-asserted-by":"publisher","first-page":"10626","DOI":"10.1021\/bi00158a027","volume":"31","author":"A Andreadis","year":"1992","unstructured":"Andreadis, A., Brown, W. M. & Kosik, K. S. Structure and novel exons of the human tau gene. Biochemistry 31, 10626\u201310633 (1992).","journal-title":"Biochemistry"},{"key":"BFnrneurol201143_CR112","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","volume":"3","author":"M Goedert","year":"1989","unstructured":"Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D. & Crowther, R. A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519\u2013526 (1989).","journal-title":"Neuron"},{"key":"BFnrneurol201143_CR113","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/hmg\/8.4.711","volume":"8","author":"M Baker","year":"1999","unstructured":"Baker, M. et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8, 711\u2013715 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201143_CR114","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ng1508","volume":"37","author":"H Stefansson","year":"2005","unstructured":"Stefansson, H. et al. A common inversion under selection in Europeans. Nat. Genet. 37, 129\u2013137 (2005).","journal-title":"Nat. Genet."},{"key":"BFnrneurol201143_CR115","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/ana.410410222","volume":"41","author":"C Conrad","year":"1997","unstructured":"Conrad, C. et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann. Neurol. 41, 277\u2013281 (1997).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201143_CR116","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/WNL.56.12.1702","volume":"56","author":"H Houlden","year":"2001","unstructured":"Houlden, H. et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56, 1702\u20131706 (2001).","journal-title":"Neurology"},{"key":"BFnrneurol201143_CR117","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1093\/hmg\/ddi361","volume":"14","author":"R Rademakers","year":"2005","unstructured":"Rademakers, R. et al. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum. Mol. Genet. 14, 3281\u20133292 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201143_CR118","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/jmg.2005.031377","volume":"42","author":"AM Pittman","year":"2005","unstructured":"Pittman, A. M. et al. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J. Med. Genet. 42, 837\u2013846 (2005).","journal-title":"J. Med. Genet."},{"key":"BFnrneurol201143_CR119","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/00005072-199906000-00011","volume":"58","author":"O Bugiani","year":"1999","unstructured":"Bugiani, O. et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J. Neuropathol. Exp. Neurol. 58, 667\u2013677 (1999).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol201143_CR120","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/1531-8249(200012)48:6<939::AID-ANA17>3.0.CO;2-1","volume":"48","author":"MG Spillantini","year":"2000","unstructured":"Spillantini, M. G. et al. A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann. Neurol. 48, 939\u2013943 (2000).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201143_CR121","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/mds.21970","volume":"23","author":"G Rossi","year":"2008","unstructured":"Rossi, G. et al. The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome. Mov. Disord. 23, 892\u2013895 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201143_CR122","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/humu.20086","volume":"24","author":"R Rademakers","year":"2004","unstructured":"Rademakers, R., Cruts, M. & van Broeckhoven, C. The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum. Mutat. 24, 277\u2013295 (2004).","journal-title":"Hum. Mutat."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2011.43.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2011.43","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2011.43.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T04:03:29Z","timestamp":1686024209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2011.43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,12]]},"references-count":122,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["BFnrneurol201143"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2011.43","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,12]]},"assertion":[{"value":"12 April 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}